These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD; Schizophr Res; 2019 Jun; 208():41-43. PubMed ID: 30745066 [TBL] [Abstract][Full Text] [Related]
5. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511 [TBL] [Abstract][Full Text] [Related]
6. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Cannon TD; Chung Y; He G; Sun D; Jacobson A; van Erp TG; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Jeffries C; Seidman LJ; Tsuang M; Walker E; Woods SW; Heinssen R; Biol Psychiatry; 2015 Jan; 77(2):147-57. PubMed ID: 25034946 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait? Khoury R; Nasrallah HA Schizophr Res; 2018 Sep; 199():31-38. PubMed ID: 29703661 [TBL] [Abstract][Full Text] [Related]
8. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Chung Y; Jacobson A; He G; van Erp TG; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Heinssen R; Cannon TD Mol Neuropsychiatry; 2015 May; 1(1):13-22. PubMed ID: 26005673 [TBL] [Abstract][Full Text] [Related]
9. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Cao H; McEwen SC; Chung Y; Chén OY; Bearden CE; Addington J; Goodyear B; Cadenhead KS; Mirzakhanian H; Cornblatt BA; Carrión RE; Mathalon DH; McGlashan TH; Perkins DO; Belger A; Seidman LJ; Thermenos H; Tsuang MT; van Erp TGM; Walker EF; Hamann S; Anticevic A; Woods SW; Cannon TD Schizophr Bull; 2019 Jun; 45(4):924-933. PubMed ID: 30215784 [TBL] [Abstract][Full Text] [Related]
10. Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians. Woodberry KA; Shapiro DI; Bryant C; Seidman LJ Harv Rev Psychiatry; 2016; 24(2):87-103. PubMed ID: 26954594 [TBL] [Abstract][Full Text] [Related]
11. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up. Brandizzi M; Valmaggia L; Byrne M; Jones C; Iwegbu N; Badger S; McGuire P; Fusar-Poli P J Psychiatr Res; 2015 Jun; 65():115-23. PubMed ID: 25837413 [TBL] [Abstract][Full Text] [Related]
12. The prodrome and clinical risk for psychotic disorders. Goulding SM; Holtzman CW; Trotman HD; Ryan AT; Macdonald AN; Shapiro DI; Brasfield JL; Walker EF Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):557-67. PubMed ID: 24012073 [TBL] [Abstract][Full Text] [Related]
13. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383 [TBL] [Abstract][Full Text] [Related]
14. Mapping prodromal psychosis: a critical review of neuroimaging studies. Fusar-Poli P; McGuire P; Borgwardt S Eur Psychiatry; 2012 Apr; 27(3):181-91. PubMed ID: 21940151 [TBL] [Abstract][Full Text] [Related]
15. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample. Osborne KJ; Mittal VA Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247 [TBL] [Abstract][Full Text] [Related]
16. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Koutsouleris N; Riecher-Rössler A; Meisenzahl EM; Smieskova R; Studerus E; Kambeitz-Ilankovic L; von Saldern S; Cabral C; Reiser M; Falkai P; Borgwardt S Schizophr Bull; 2015 Mar; 41(2):471-82. PubMed ID: 24914177 [TBL] [Abstract][Full Text] [Related]